Business Segments Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2025-06-20 am EDT			5-day change	1st Jan Change
475.80 ^DKK	-2.58%		-8.36%	-23.77%

Jun. 20	US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list	RE
Jun. 20	US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list	RE

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (DKK)

Fiscal Period: December	2020	2021	2022	2023	2024
Pharmaceutical Products
Diabetes and Obesity Care	108B	122B	156B	215B	272B
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	4.62B	4.9B	5.7B	8.2B	7.1B
Operating Income	43.74B	49.54B	67.4B	99.62B	128B
Rare Disease	18.93B	19.2B	20.54B	17.16B	18.64B
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	1.13B	1.13B	1.66B	1.22B	1.44B
Operating Income	10.38B	9.11B	7.41B	2.95B	620M
Total Assets	-	-	-	-	-
Total Assets	-	-	-	-	-

Geographical breakdown of sales (DKK)

Fiscal Period: December	2020	2021	2022	2023	2024
United States of America (USA)	57.82B	63.01B	84.66B	128B	167B
Total Assets	-	-	-	-	57.14B
CAPEX	-	-	-	-	-
Total Assets	-	-	-	-	177B
EMEA	34.3B	37.71B	44.24B	50.87B	60.4B
Rest of the World	17.45B	19.81B	25.4B	28.08B	33.33B
Region China	14.08B	16.02B	16.21B	16.69B	18.5B
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
North America (Excl. US)	3.29B	4.25B	6.45B	9.1B	10.77B
Total Assets	-	-	-	-	-
Africa, Asia, Middle East and Oceania (AAMEO)	-	-	-	-	-
Total Assets	-	-	-	-	-
Latin America	-	-	-	-	-
Total Assets	-	-	-	-	-
Pacific	-	-	-	-	-
Total Assets	-	-	-	-	-
Japan & Korea	-	-	-	-	-
Total Assets	-	-	-	-	-
North America	-	-	-	-	-
Total Assets	-	-	-	-	-
Europe	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
International Operations	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-